Diebold Nixdorf, Incorporated (DBD) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
DBD Revenue Growth
Revenue Breakdown (FY 2025)
DBD's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
DBD Revenue Analysis (2014–2025)
As of May 8, 2026, Diebold Nixdorf, Incorporated (DBD) generated trailing twelve-month (TTM) revenue of $3.86 billion, reflecting solid growth of +6.0% year-over-year. The most recent quarter (Q1 2026) recorded $891.8 million in revenue, down 19.2% sequentially.
Looking at the longer-term picture, DBD's 5-year compound annual growth rate (CAGR) stands at -0.5%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $4.61 billion in 2017.
Revenue diversification analysis shows DBD's business is primarily driven by Service (57%), and Product (43%). With over half of revenue concentrated in Service, the company maintains significant focus in this area while developing other growth vectors.
When compared to Technology sector peers including NATL (+3.1% YoY), PAX, and FIS (+7.6% YoY), DBD has underperformed the peer group in terms of revenue growth. Compare DBD vs NATL →
DBD Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| DBDCurrent | $3.9B | +6.0% | -0.5% | 8.8% | |
 NATL | $4.4B | +3.1% | - | 11.0% | |
 PAX | $384M | - | - | 34.2% | |
 FIS | $10.7B | +7.6% | -3.2% | 16.5% | |
 FISV | $21.2B | +1.9% | +7.4% | 26.9% | |
 MA | $32.8B | - | - | 59.2% |
DBD Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $3.81B | +1.5% | $1.00B | 26.4% | $334.6M | 8.8% |
| 2024 | $3.75B | -0.3% | $920.0M | 24.5% | $182.1M | 4.9% |
| 2023 | $3.76B | +8.7% | $876.2M | 23.3% | $86.9M | 2.3% |
| 2022 | $3.46B | -11.4% | $757.3M | 21.9% | $-211,700,000 | -6.1% |
| 2021 | $3.91B | +0.1% | $1.04B | 26.7% | $137.1M | 3.5% |
| 2020 | $3.90B | -11.5% | $1.03B | 26.5% | $24.0M | 0.6% |
| 2019 | $4.41B | -3.7% | $1.08B | 24.4% | $235.0M | 5.3% |
| 2018 | $4.58B | -0.7% | $890.9M | 19.5% | $-362,900,000 | -7.9% |
| 2017 | $4.61B | +39.0% | $1.03B | 22.3% | $135.4M | 2.9% |
| 2016 | $3.32B | +37.1% | $747.2M | 22.5% | $60.5M | 1.8% |
See DBD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DBD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DBD vs NVDA
Side-by-side business, growth, and profitability comparison vs NVIDIA Corporation.
Start ComparisonDBD — Frequently Asked Questions
Quick answers to the most common questions about buying DBD stock.
Is DBD's revenue growth accelerating or slowing?
DBD maintains +6.0% revenue growth, in line with its 5-year CAGR of -0.5%. TTM revenue stands at $3.9B. Growth rate remains consistent with historical average.
What is DBD's long-term revenue growth rate?
Diebold Nixdorf, Incorporated's 5-year revenue CAGR of -0.5% reflects the sustained expansion pattern. Current YoY growth of +6.0% is near this long-term average.
How is DBD's revenue distributed by segment?
DBD reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.